Inspire Pharmaceuticals Inc (NASDAQ:ISPH) to Present at Noble Financial Mad Max Equity Conference August 18

Inspire Pharmaceuticals Inc (NASDAQ:ISPH) will speak at the Noble Financial Mad Max Equity Conference on Monday, August 18 at 4:00 pm ET.  A webcast of the presentation will be available on the company’s investor relations website at ir.inspirepharm.com.

Inspire Pharmaceuticals, Inc. (Inspire) is a biopharmaceutical company focusing on discovering, developing and commercializing prescription pharmaceutical products in disease areas with commercial potential or unmet medical needs.

The Company’s portfolio of products and product candidates include Elestat, Restasis, AzaSite, Prolacria, Denufosol tetrasodium, Epinastine nasal spray and INS115644. It co-promotes Elestat and Restasis in the United States under agreements with Allergan, Inc. (Allergan). Elestat and Restasis are trademarks owned by Allergan. AzaSite is a trademark owned by InSite Vision Incorporated (InSite Vision).

Its ophthalmic products and product candidates are concentrated in the allergic and bacterial conjunctivitis, dry eye disease and glaucoma indications. Inspire’s respiratory/allergy product candidates are concentrated in the treatment of respiratory complications of cystic fibrosis and seasonal allergic rhinitis indications.

Read more Business News on The Global Market Directory.

About The Global Market Directory (TheGMD)

TheGMD provides an online global directory listing featuring public companies, stock brokers, brokerage firms and individuals.  The GMD provides profiles for Brokerage Firms, Stock Brokers and Individuals in addition to Public Companies.

The GMD is a division of TransWorldNews, Inc. Companies can utilize the TransWorldNews press release distribution services and have all news releases attached to their GMD profile.

Create your profile on The Global Market Directory.